In the Mar 2026 quarter (standalone), Kothari Sugars and Chemicals reported sales of ₹42.01 Cr, up 16.3% from Mar 2025, and net profit of ₹0.62 Cr. For the year to Mar 2026, sales were ₹247 Cr and net profit ₹6.98 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 163 | 113 | 132 | 94.44 | 89.78 | 102 | 82.79 | 36.11 | 66.77 | 68.07 | 70.18 | 42.01 |
| Expenses | 134 | 102 | 133 | 91.36 | 88.69 | 91.09 | 79.47 | 38.95 | 65.66 | 76.12 | 76.27 | 44.92 |
| Operating Profit | 29.84 | 11.74 | −0.28 | 3.12 | 1.09 | 10.67 | 3.41 | −2.87 | 1.10 | −7.98 | −6.05 | −2.90 |
| OPM % | 18.3% | 10.3% | −0.2% | 3.3% | 1.2% | 10.5% | 4.1% | −8.0% | 1.6% | −11.7% | −8.6% | −6.9% |
| Other Income | 2.54 | 3.62 | 4.03 | 5.26 | 3.97 | 3.57 | 9.18 | 6.09 | 5.86 | 2.26 | 22.43 | 1.76 |
| Interest | 1.47 | 1.07 | 0.24 | 0.80 | 2.21 | 0.83 | 0.00 | 0.57 | 1.68 | 1.47 | 0.60 | 0.78 |
| Depreciation | 3.35 | 3.64 | 3.55 | 3.78 | 3.67 | 3.67 | 3.68 | 3.67 | 3.63 | 3.64 | 3.64 | 3.69 |
| Profit before tax | 27.42 | 10.61 | −0.01 | 3.78 | −0.81 | 9.69 | 8.86 | −1.00 | 1.63 | −10.77 | 12.10 | −5.57 |
| Tax % | 34.8% | 51.3% | −3,850.0% | −48.8% | −35.4% | 35.7% | 39.2% | −31.7% | 23.7% | −33.0% | 1.3% | −111.4% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.02 | 0.00 | 1.01 | 0.00 | 19.09 | 0.00 |
| Net Profit | 17.85 | 5.17 | 0.75 | 5.63 | −0.52 | 6.24 | 5.39 | −0.68 | 1.24 | −7.22 | 11.93 | 0.62 |
| EPS (Rs) | 2.15 | 0.61 | 0.08 | 0.67 | −0.05 | 0.74 | 0.64 | −0.07 | 0.14 | −0.86 | 1.43 | 0.07 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 247 | 317 | 287 | 333 | 353 | 420 | 423 | 610 | 504 | 311 | 247 | 247 |
| Expenses | 229 | 280 | 259 | 310 | 325 | 387 | 373 | 549 | 459 | 298 | 263 | 263 |
| Operating Profit | 18.07 | 36.11 | 28.09 | 23.05 | 28.07 | 33.09 | 50.15 | 61.22 | 44.14 | 12.03 | −16.03 | −15.83 |
| OPM % | 7.0% | 11.0% | 10.0% | 7.0% | 8.0% | 8.0% | 12.0% | 10.0% | 9.0% | 4.0% | −6.0% | −6.4% |
| Other Income | 7.02 | −1.01 | −5.02 | 20.07 | 11.03 | 10.04 | 8.02 | 12.04 | 15.06 | 23.07 | 32.13 | 32.31 |
| Interest | 7.01 | 8.01 | 6.01 | 7.01 | 7.01 | 5.01 | 4.01 | 4.01 | 4.01 | 4.01 | 4.01 | 4.53 |
| Depreciation | 15.01 | 15.01 | 14.01 | 13.01 | 13.01 | 14.01 | 14.01 | 14.01 | 14.01 | 15.01 | 15.01 | 14.60 |
| Profit before tax | 2.99 | 12.97 | 2.99 | 22.95 | 18.94 | 22.95 | 38.91 | 54.91 | 41.89 | 16.97 | −2.99 | −2.61 |
| Tax % | 58.0% | 17.0% | 82.0% | 44.0% | −2.0% | 19.0% | 14.0% | 24.0% | 30.0% | 38.0% | −351.0% | — |
| Exceptional items | 0.00 | −5.02 | −2.01 | 1.01 | 5.02 | 5.02 | 1.01 | 6.02 | 1.01 | 6.02 | 21.07 | 20.10 |
| Net Profit | 0.99 | 9.98 | 0.00 | 12.98 | 18.97 | 18.97 | 33.91 | 41.92 | 28.92 | 9.98 | 6.98 | 6.57 |
| EPS (Rs) | 0.13 | 1.25 | 0.05 | 1.52 | 2.33 | 2.28 | 4.10 | 5.05 | 3.55 | 1.25 | 0.79 | 0.78 |
| Dividend payout % | 0.0% | 40.0% | 0.0% | 33.0% | 0.0% | 0.0% | 0.0% | 19.9% | 14.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 82.87 | 82.91 | 82.87 | 82.94 | 82.88 | 82.89 | 82.94 | 82.97 | 82.93 | 82.89 | 82.92 | 82.94 |
| Reserves | 33.92 | 34.88 | 48.86 | 55.88 | 68.86 | 83.83 | 103 | 137 | 175 | 195 | 206 | 213 |
| Borrowings | 166 | 175 | 146 | 120 | 116 | 84.21 | 36.06 | 57.09 | 38.04 | 70.13 | 50.07 | 70.12 |
| Other Liabilities | 74.64 | 75.81 | 103 | 110 | 123 | 124 | 119 | 118 | 137 | 135 | 111 | 80.39 |
| Total Liabilities | 358 | 368 | 380 | 370 | 391 | 375 | 341 | 395 | 433 | 483 | 451 | 446 |
| Fixed Assets | 208 | 194 | 191 | 177 | 167 | 171 | 162 | 152 | 152 | 163 | 150 | 163 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 1.01 | 0.00 | 0.00 | 1.01 | 9.03 | 0.00 | 4.01 | 0.00 |
| Investments | 18.02 | 18.01 | 20.02 | 33.03 | 48.05 | 30.02 | 58.02 | 71.08 | 72.03 | 100 | 133 | 121 |
| Other Assets | 131 | 155 | 169 | 159 | 174 | 172 | 121 | 170 | 200 | 219 | 162 | 160 |
| Inventories | 98.69 | 116 | 144 | 128 | 138 | 125 | 86.81 | 129 | 136 | 169 | 97.81 | 118 |
| Trade receivables | 8.03 | 9.03 | 14.04 | 18.05 | 17.05 | 27.09 | 21.07 | 25.10 | 28.11 | 22.07 | 17.06 | 14.05 |
| Cash & equivalents | 8.98 | 16.97 | 2.99 | 2.99 | 7.98 | 0.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 | 0.00 |
| Total Assets | 358 | 368 | 380 | 370 | 391 | 375 | 341 | 395 | 433 | 483 | 451 | 446 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | −13.02 | 25.04 | 25.04 | 37.08 | 26.04 | 27.06 | 82.07 | −3.01 | 45.04 | 16.03 | 52.04 | −14.02 |
| Cash from investing activity | 1.01 | 4.01 | −10.01 | 0.00 | −11.01 | 3.01 | −29.04 | −13.02 | −19.03 | −36.02 | −28.03 | −2.01 |
| Cash from financing activity | 18.08 | −22.08 | −28.09 | −36.15 | −10.04 | −30.11 | −1.01 | −11.04 | −15.05 | −12.05 | −4.02 | −5.02 |
| Net cash flow | 6.03 | 8.03 | −14.06 | 1.01 | 5.02 | 0.00 | 52.17 | −27.12 | 11.05 | −32.12 | 21.07 | −21.07 |
| Capex | 0.55 | 0.43 | 11.31 | 1.36 | 4.79 | 17.23 | 4.28 | 4.25 | 21.41 | 17.36 | 5.41 | 24.35 |
| Free cash flow | −13.02 | 25.06 | 13.01 | 36.06 | 22.02 | 10.02 | 77.12 | −7.02 | 24.04 | −2.01 | 47.06 | −38.09 |
| CFO / OP % | −123.9% | 143.1% | 74.1% | 141.1% | 133.1% | 110.1% | 263.1% | 8.1% | 88.1% | 51.1% | 472.1% | 82.1% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 8 | 13 | 15 | 22 | 18 | 27 | 17 | 20 | 16 | 15 | 19 | 20 |
| Inventory days | 138 | 235 | 234 | 223 | 215 | 180 | 100 | 164 | 116 | 179 | 160 | 230 |
| Days payable | 46 | 61 | 89 | 134 | 128 | 112 | 96 | 100 | 74 | 94 | 111 | 84 |
| Cash conversion cycle | 102 | 188 | 161 | 113 | 107 | 98 | 23 | 87 | 60 | 102 | 70 | 168 |
| Working capital days | 20 | 8 | 0 | −17 | −10 | −1 | 2 | 16 | 24 | 30 | 36 | 206 |
| ROCE % | 1.0% | 3.0% | 9.0% | 7.0% | 9.9% | 8.0% | 10.0% | 17.0% | 18.0% | 14.0% | 3.0% | −6.0% |
For the Mar 2026 quarter, Kothari Sugars and Chemicals reported sales of ₹42.01 Cr, up 16.3% year on year and net profit of ₹0.62 Cr. The operating margin was −6.9%.
Kothari Sugars and Chemicals' sales for the year to Mar 2026 were ₹247 Cr; over the last twelve months they were ₹247 Cr.
Net profit for the year to Mar 2026 was ₹6.98 Cr, and ₹6.57 Cr over the last twelve months. Earnings per share over the same trailing period were ₹0.78.
Kothari Sugars and Chemicals reported borrowings of ₹70.12 Cr at Mar 2026, against cash and equivalents of ₹0 Cr.
Cash from operations was −₹14.02 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹38.09 Cr.